Home Archive
Archive
2018 Volume 39 Issue 5  Published: 2018-05-10
    Recommendation
  • Qing-wei LI , Zheng LU
    doi: 10.13683/j.wph.2018.05.001

    The American academy of sleep medicine (AASM) issued the clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults in 2016. Based on this guideline and some existing reviews, this article gives an interpretation on the insomnia drug therapy of 14 drugs.

  • Topic
  • Jing-yi MAO , Ming ZHANG , Bing LI
    doi: 10.13683/j.wph.2018.05.002

    Verruca plana is the common skin disease with high recurrence rate. Its treatments are including traditional Chinese medicine (TCM) and western drugs. The western medicine treatment includes vitamin A acid, salicylic acid and thymic five peptides and imiquimod. However, the TCM treatment is based on syndrome differentiation and external treatment to remove warts, which has the advantage of adding or subtraction prescriptions. This article briefly reviews the recent clinical evaluation of the verruca plana treatment by both TCM and western drugs.

  • Topic
  • Juan-juan ZHANG , Wei-an MAO
    doi: 10.13683/j.wph.2018.05.003

    Herpes zoster is a viral dermatosis caused by the varicella-zoster virus, which affects the nerves and skin. The elderly patients may suffer from severe complications such as post-herpetic neuralgia (PHN). Usually, the acute stage of clinical herpes zoster can be treated with traditional Chinese medicine (TCM) and western drugs to relieve the pain and reduce the occurrence of serious complications. This article reviews the recent progress of herpes zoster treatment with TCM and western drugs.

  • Topic
  • Jie ZHOU , Fu-lun LI , Wei-an MAO
    doi: 10.13683/j.wph.2018.05.004

    Vitiligo is a kind of complicated disease, which is hard to be cured by clinical routine treatment. Generally, the commonly used western drugs include glucocorticoid and calcineurin inhibitor. The traditional Chinese medicine (TCM) is used as liver and kidney tonic to activate blood circulation and remove blood stasis, it also can be used internal and external administration, and it is relatively safe. This review briefly summarizes the efficacy and clinical evaluation of vitiligo treated by TCM and western drugs.

  • Article
  • Ping GUO , Hui HUANG , Chao KANG , Yun ZHONG , Na LI , Bing ZHANG
    doi: 10.13683/j.wph.2018.05.005
    Objective

    To evaluate the effect of anti-hepatitis B virus traditional Chinese medicine ZYD on the biological behavior of human hepatocellular carcinoma cells SMMC-7721, and to discuss their possible mechanism.

    Methods

    The cell proliferation was detected by MTT; the cell adhesion ability was detected according to cell adhesion experiment; the cell migration ability was determined by scratch test; the cell cycle and apoptosis were tested by flow cytometry, and the reverse-transcription-polymerase chain reaction (RT-PCR) was applied to detect the expression of MMP-2、MMP-9, TIMP-1, Snail, Vimentin, and Prx-1 mRNA.

    Results

    ZYD could significantly inhibit the proliferation of SMMC-7721 cells, and the inhibitory effect was better than each herb component. ZYD could inhibit the adhesion of SMMC-7721 cells in a dose-dependent manner, and could reduce the migratory ability of SMMC-7721 cells by dose-effect and time-effect manner. ZYD could promote apoptosis of SMMC-7721 cells and lead to cell cycle block in S stage. Furthermore, the expressions of MMP-2 and Snail mRNA in SMMC-7721 cells were significantly down-regulated at each dose, while high dose (1 000 μg/ml) of ZYD could significantly reduce the expression of MMP-9 mRNA.

    Conclusion

    ZYD can inhibit the proliferation of SMMC-7721 hepatoma cells by promoting cellular apoptosis and blocking cell cycle in S stage. Moreover, ZYD can suppress the metastasis of hepatocellular carcinoma cells by decreasing Snail, MMP-2 and MMP-9 mRNA expression.

  • Article
  • Qin-qin ZHANG , Zong-an LIANG , Xian-mei QIN
    doi: 10.13683/j.wph.2018.05.006
    Objective

    To study the efficacy and safety of recombinant human prourokinase in the treatment of acute pulmonary embolism (APE).

    Methods

    A total of 78 cases of APE patients from September 2015 to August 2016 admitted were divided into observation group and control group according to the order of admission. The observation group was received recombinant human prourokinase, and the control group was given urokinase for treatment. The total effective rates of the two groups were calculated, and the blood gas, blood pressure, coagulation and the fibrinolysis related indexes of two groups before and after treatment were compared. The incidences of adverse drug reactions in two groups were observed.

    Results

    After treatment, the total effective rate of the observation group was higher than that of the control group (89.74% vs 61.54%, P<0.05). Compared with before treatment, the blood gas, blood pressure, coagulation and the fibrinolysis related indexes of two groups after treatment were improved (P<0.01). The arterial oxygen pressure and systolic blood pressure in observation group were higher than those in control group [(88.96±8.43) mmHg, (132.98±14.65) mmHg vs (78.98±7.87) mmHg, (122.97±12.89) mmHg](P<0.05, P<0.01), and the pulmonary artery systolic pressure was lower than that of control group [(32.98±3.84) mmHg vs (45.98±4.87)mmHg](P<0.01). The tissue type plasminogen activator, plasminogen activator inhibitor-1, coagulation regulator protein, protein C, protein S, plasma D-dimer (DD) in observation group were lower than those in control group [(6.04±0.61) μg/L, (48.21±4.25) μg/L, (3.51±0.32) μg/L, (2.14±0.26) mg/L (13.56±1.46) mg/L, and (0.72±0.04) mg/L vs (9.87±0.93) μg/L, (54.32±5.11) μg/L, (5.15±0.53) μg/L, (3.24±0.37) mg/L, (19.58±1.94) mg/L, and (1.03±0.09) mg/L](P<0.01). The adverse drug reaction rate in observation group was lower than that in control group (7.69% vs 35.90%, P<0.05).

    Conclusion

    Recombinant human prourokinase is effective in the treatment of APE. It can effectively improve blood gas, blood pressure, coagulation and the fibrinolysis related indexes, and has less adverse drug reactions such as bleeding.

  • Article
  • Hui-ling WANG , Hai-long SI , Li-fang WANG , Hai-bin DENG , Zhen-ye XU
    doi: 10.13683/j.wph.2018.05.007
    Objective

    To observe the effects of Feiyanning granule on the tumor associated macrophages (TAMs) and suppressing growth of Lewis lung carcinoma in mice.

    Methods

    The tumor-bearing model was established by subcutaneously injecting Lewis cells to C57BL/6 mice. Then the C57BL/6 mice were divided into model group (n=8), cisplatin group (n=8), and Feiyanning granule group (n=8), and treated with corresponding drugs. The quality of life and the tumor inhibition rate were observed after 14 days. The mRNA expression of MMP-2, MMP-9, NF-κB p65 and STAT 3 were detected by real-time quantitative PCR (RT-qPCR). The ratios of M1 and M2 were measured by flow cytometry method. The expression of p-STAT 3 protein was detected by Western-Blot.

    Results

    According to the quality of life, the Feiyanning granule group was better. Feiyanning granule was able to suppress Lewis lung carcinoma growth. Compared with model group, the M2 of Feiyanning granule group and cisplatin group were significantly lower (P<0.05). Compared with model group and cisplatin group, the M1 of Feiyanning group was significantly higher (P<0.05). The result of RT-qPCR showed that the expressions of MMP-2, MMP-9 and NF-κB p65 mRNA in both cisplatin group and Feiyanning granule group were obviously lower than those in model groups (P<0.05), and the expressionsin Feiyanning granule group were lower than those in cisplatin group (P<0.05). The result of Western-Blot showed that the protein expressions of p-STAT 3 in both Feiyanning granule group and cisplatin group was lower than those in model group.

    Conclusion

    Feiyanning granule can suppress Lewis lung carcinoma growth. Its mechanisms may be related to the intervention of TAMs through NF-κB and STAT 3 signal pathway.

  • Article
  • Ye GU , Lai-fang ZHU
    doi: 10.13683/j.wph.2018.05.008
    Objective

    To evaluate the clinical efficacy and outcome analysis of policresulen solution in the treatment of cervical human papillomavirus (HPV) infection with cervical erosion.

    Methods

    A total of 218 patients with cervical HPV infection and cervical erosion during January 2014 to January 2016 were enrolled and divided into the treatment group (treated with policresulen solution for cervical administration, n=109) and the control group (treated with recombinant human interferon α2b vaginal effervescent capsule for vaginal administration, n=109). The HPV levels, cervical erosion and related treatment symptoms in two groups after 3 courses were compared. The HPV outcome in two groups was followed up.

    Results

    HPV negative rate in treatment group was higher than that in control group (P<0.05). The effect of cervical erosion and related symptoms in treatment group was better than those in control group (P<0.05). The average clearance time of HPV in treatment group was 8.34 months (95% CI: 7.39~9.31), the median clearance time was 6 months (95% CI: 4.95~7.05); The average clearance time in control group was 9.18 months (95% CI: 8.27~10.10) and the median clearance time was 8 months (95% CI: 7.31~8.69), the difference was statistically significant (P<0.05).

    Conclusion

    Policresulen solution has effective clinical results in the treatment of cervical HPV infection patients with cervical erosion, and can shorten the HPV negative time.

  • Article
  • Qi-fen ZHU , Bin ZHENG , Ren-jie YAN , Xiao-tao XU , Shu-yun QU , Li LIU
    doi: 10.13683/j.wph.2018.05.009
    Objective

    To investigate the immunomodulatory effects of Yupingfeng granule on the immunosuppression induced by dexamethasone in immature mice.

    Methods

    BALB/c mice (3 weeks old) were randomly divided into four groups: control group, model group, Yupingfeng group and Yupingfeng +model group, ten mice in each group. The control group and model group were given by gavage once a day for 21 d with drinking water; The Yupingfeng group and Yupingfeng +model group were given by gavage once a day for 21 d with Yupingfeng granule (1.8 g/kg); the model group and Yupingfeng+model group were given by intraperitoneal injection on day 15 and 16 with dexamethasone (12 mg/kg). After last administration, the mice were weighed and sacrificed, the organ dexamethasone in spleen and thymus were measured. Meanwhile, the spleen cells and the peritoneal macrophage were isolated and purified for cell function test. Also, the nature kill (NK) cells and CD4+/CD8+ T cells were isolated from mice blood for testing.

    Results

    Compared with the control group, body weight, thymus and spleen index, lymphocyte proliferation activity, NK cell killing activity, macrophage phagocytosis index and spleen lymphocyte CD4+/CD8+ ratio in model group were decreased, and the proportion of spleen lymphocyte apoptosis in model group was increased. Compared with the model group, the body weight, thymus and spleen index, lymphocyte proliferation activity, NK cell killing activity, macrophage phagocytosis index and spleen lymphocyte CD4+/CD8+ ratio in Yupingfeng+model group were increased, and the proportion of spleen lymphocyte apoptosis in Yupingfeng+model group was decreased, the differences were statistically significant (P<0.05 or P<0.01).

    Conclusion

    Yupingfeng granule can significantly improve the immune function of the immunosuppressive immature mice induced by dexamethasone.

  • Article
  • Xue-hua DAI , Yong-mei YE , Ting GUO
    doi: 10.13683/j.wph.2018.05.010
    Objective

    To explore the clinical effect of the Fuzheng Huayu method combined with western medicine therapy in the treatment of adenomyosis and the effect on the degree of dysmenorrhea.

    Methods

    A total of 82 patients with adenomyosis from July 2015 to July 2017 were selected and randomly divided into the control group and the observation group at 41 cases each group. The control group was treated with conventional western medicine therapy (mifepristone tablets and ibuprofen sustained-release capsules). The observation group was additionally treated with the Fuzheng Huayu method (Neiyi Xiaozheng decoction and acupuncture treatment) on the basis of the control group. The uterine volume was observed by B ultrasonography, the dysmenorrhea degree was evaluated by the visual analogue score (VAS), and the total effective rate and the incidence of adverse drug reactions in both two groups were calculated.

    Results

    The total effective rate in observation group was 95.12%, which was higher than that in control group (80.49%), and the difference was statistically significant (P < 0.05). The uterine volume and the VAS after treatment in observation group were significantly lower than those in control group. The difference was statistically significant (P<0.05). The incidence of adverse drug reactions during treatment was 9.76% in observation group and 14.63% in control group respectively, which was no significant difference between two groups (P>0.05).

    Conclusion

    Fuzheng Huayu method combined with western medicine therapy in the treatment of adenomyosis can achieve satisfactory results, and it can significantly improve dysmenorrhea symptoms in patients with high safety.

  • Article
  • Cheng-long FAN , Yuan ZHANG , Bei-lin ZHU , Hui PAN , Guo-rong FAN
    doi: 10.13683/j.wph.2018.05.011
  • Article
  • Hui ZHU , Jian JIN
    doi: 10.13683/j.wph.2018.05.012
  • Review
  • Quan CHEN , Xiao-di HUANG , Yan WAN , Bai LI
    doi: 10.13683/j.wph.2018.05.013

    Iron existed in normal cells and various kinds of tumor cells is a kind of life indispensable elements, which widely participate in various important metabolic life processes. However, the iron metabolism disorder may lead to iron deficiency or iron overload to causes the corresponding diseases. The low iron state caused by physical exercise and the iron overload of cancer patients are correlated with ferritin, hepcidin, transferrin and transferrin receptor 1. Usually, the physical exercise can regulate the iron metabolism in cancer patients. This review describes that the physical exercise may inhibit malignant tumor growth through the way of regulating iron metabolism.

  • Review
  • Gang ZHENG
    doi: 10.13683/j.wph.2018.05.014

    In recent years, the drug therapy strategy of chronic heart failure (CHF) has been changed from the cardiac stimulator, diuretic and vasodilator into the core of neurohormonal therapy. The CHF treatment objective is not only to improve the symptoms and life quality of patients, but also to reconfigurate the myocardial function. In order to prevent and delay the development of myocardial remodeling, and reduce the hosptitalization rate and mortality of CHF patients effectively. This review describes the relevant studies of cardiovascular drugs and their clinical application.

News